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Abstract
Preterm labor affects up to 20% of pregnancies, is considered a main cause of associated neonatal
morbidity and mortality and is responsible for neonatal care costs of multimillion euros. In spite of
that, the commercial market for this clinical indication is rather limited, which may be also related
to high liability. Consequently, with only a few exceptions, preterm labor is not in the orbit of great
interest of the pharmaceutical industry. Coordinated effort of research community may bring the
change and help required to reduce the influence of this multifactorial syndrome on society.
Between the novel techniques that are being explored in a SAFE (The Special Non-Invasive
Advances in Fetal and Neonatal Evaluation Network) group, there are new research models of
preterm labor as well as novel methodology of analysis of biological signals. In this article, we briefly
describe new clinical and nonclinical human models of preterm labor as well as summarize some
novel methods of data processing and analysis that may be used in the context of preterm labor.
Background
Preterm labor now constitutes the major cause for neona-
tal mortality in developed countries. In spite of decades of
ongoing research, its pathophysiology still remains not
fully discovered [1,2], and consequently – the specific
pharmacologic armory to treat preterm labour is not large.
Notwithstanding multimillion euro costs of neonatal
care, the annual percentage of cases of preterm birth is rel-
atively limited. As a result, most of the pharmaceutical
industry considers this segment of market as small one
and which additionally is connected to high liability,
meaning: not attractive [3]. However, this hides the fact
that the numbers of preterm births in Europe reaches hun-
dreds of thousands.
Ethical issues in clinical studies significantly limit the pos-
sibility of using placebo-controlled protocols. On the other
hand, the application of alternative protocols drastically
reduces the chances of drug candidates in the process of reg-
istration. The effect of combination of above-mentioned
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factors creates the situation where very few medicines are
labeled for use in pregnancy, and especially, preterm labor.
Considering the whole situation surrounding preterm
labor, it appears that only a coordinated effort of research
networks, such as SAFE (The Special Non-Invasive
Advances in Fetal and Neonatal Evaluation Network) and
those involved in preterm labour, is capable of bringing the
new data that could be of potential use in discerning its
pathophysiology and point to new pharmacological tar-
gets.
Therefore, in this setting there is much to be done towards
solving this important problem. Here, we put forward
new clinical and non-clinical models of uterine contrac-
tile activity together with new methods towards the detec-
tion and processing of biological signals that can be used
as significant examples to build upon between collaborat-
ing partners.
New research models of preterm labor
One of the major concerns in studies on preterm labor,
especially on uterine contractile activity is that practically
none of the models is adequately sufficient and easy to
use – mice uteri lack V1a vasopressin receptor [4], rats
present with spontaneous uterine contractility [5] and
labor in ginea pigs is characterized by the desensitization
of the progesterone receptor [6]. Studies on primates may
be considered the most valuable [7], however, the accessi-
bility of this model is significantly reduced by its costs and
ethical issues. Consequently, there is a need for both in
vivo and in vitro models that could closely reflect the reac-
tivity of human myometrium/uterus, serving in patho-
physiologic/pharmacologic studies.
Valuable information on the biology and pharmacology
of uterine contractile activity may be provided by in vitro
studies on uterine strips isolated from human pregnant/
non-pregnant women as well as in vivo human or animal
models [8-11]. One of the modifications of the in vitro
model of contractility of human myometrium presented
in the literature [12,13], may involve utilization of preg-
nant strips sampled from patients delivered preterm. In
the study conducted by Pierzynski et al. [14] we confirmed
that barusiban, a novel oxytocin antagonist effectively
reduced oxytocin-induced contractions of both preterm
and term myometrium. Such a model, although more
complicated, is to our knowledge the only one describing
human myometrium sampled from women delivered pre-
term and provides additional support for other in vitro
studies.
In vitro studies are usually preceding clinical application
of drug candidates. As ethical specificity practically
excludes testing on pregnant volunteers, there is a hectic
need for optimal in vivo model. Consideration should,
therefore, be given to the uterus of non-pregnant women
– where, aparting from the lack of significant rise in oxy-
tocin receptors as seen in late pregnancy [15], most of the
regulatory mechanisms remains unaltered (i.e. reaction to
vasopressin or prostaglandins). Measurements of intrau-
terine pressure taken in two distant parts of the non preg-
nant uterus (isthmus and fundus), thanks to a novel
analysis of signals, delivered new data on significant dif-
ferences in spatial characteristics of contractions [16-18].
Moreover, a model of contractility of non-pregnant uterus
may be used for the assessment of the influence of novel
drugs reducing uterine contractions. In one of the latest
publications, we explored the influence of short time, low
dose tamoxifen treatment on parameters of uterine con-
tractile activity of dysmenorrhoeic women [19], showing
potentially significant direct influence on parameters of
contractile activity; importantly, these would not be
detected by conventional methods of signal analysis. Even
though tamoxifen treatment may not find its place in
obstetrics, the study does illustrate that similar methodol-
ogy may be applied in the assessments of other drug can-
didates, such as novel oxytocin antagonists or calcium
channel blockers. Multifocal assessments of uterine con-
tractile activity in pregnant women may be performed by
the measurements of electric [20] or magnetic [21] activity
of the uterus, the novel approach of assessment of uterine
magnetic resonance was recently utilized for highly
advanced mathematical construction of the virtual atlas of
functional biology of human uterus [22]. Special analysis
of data may be helpful in establishing interrelations
between various parameters of contractions such as syn-
chronization or propagation and clinical outcome.
Novel analysis of signals in studies on preterm 
labor
Our advanced methods of signal processing and analysis
reported here give added support to the potential benefit
of new preclinical and clinical models of preterm labor.
Such an attitude could provide new insights into "well
known" phenomena such as uterine contractile activity.
Classical modalities of signal analysis, such as time
domain and frequency domain-based analysis are fre-
quently insufficient in providing significant biologic data
on uterine contractile activity. In the classical, so called
"time domain" analysis, studied parameters including
area under curve recording (AUC), maximal amplitude of
contractions and various statistical quantities (mean,
standard deviation, median, skewness). Although easily
computed even for short time recordings [23], these are
not sensitive enough to characterize discrete, but poten-
tially important changes in contractile activity. Also, in the
frequency domain, the Fourier transform gives no infor-
mation on the localization of the individual frequency
components [24,25], as it provides a globalised integrated
from over the whole signal.BMC Pregnancy and Childbirth 2007, 7(Suppl 1):S6 http://www.biomedcentral.com/1471-2393/7/S1/S6
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Contrary to the Fourier decomposition, the continuous
and discrete wavelet transforms allow extracting local and
global variations of the recorded contractions. Graphical
presentation of such data (scalograms) shows the distri-
bution of energy in the time-frequency plane. For normal
contractions, scalograms of the fundal and cervical signals
are very similar. In the case of dysmenorrheic contrac-
tions, patterns are quite different [25]. Studies on preg-
nant women using non-invasive approaches are currently
in progress.
In the case of bivariate sets of signals (i.e. recorded in two
distant locations of the uterus), which contain two simul-
taneously recorded time series, it appears clinically impor-
tant to understand how the variables interact. Cross-
correlation function can be employed to analyze the asso-
ciation between two time series [18,19,26]. This function
is sensitive to the phase differences and can be used to
identify time delays (time shifts) between two signals.
Time shifts may be an important indicator of propagation
of uterine contractions, which could be altered in women
in preterm labor. Figure 1 shows the running cross-corre-
lation and the instantaneous time shifts for normal uter-
ine activity. Standardized sets of signals are obtained after
subtraction of the mean from each sample of the signal.
The values of the cross-correlation coefficients correspond
to the gray levels, as it is shown on the scale bar, which is
located on the right of the running map (Figure 1, panel B
(b)). Signals of the patient with fibromyomas have dis-
turbed synchronization.
Graphical presentation of synchronization of contractions of normal (panel A) and fibromyomatous (panel B) uterus Figure 1
Graphical presentation of synchronization of contractions of normal (panel A) and fibromyomatous (panel B) 
uterus. Panel A shows the synchronization of the recording for the normal uterine activity. (a) Uterine contractions (stand-
ardized signals); (b) Running cross-correlation functions (values of the cross-correlation coefficients correspond to the gray 
levels); (c) Instantaneous time shift shows the maximal values of the cross-correlation coefficients for fixed time. Panel B illus-
trates the synchronization for the uterine activity in patients with fibromyomas; (a) Uterine contractions; (b) Running cross-
correlation functions; (c) Instantaneous time shift. In panel A, the maximal values of the cross-correlation coefficients are 
mainly located in the area of the positive time lags. In this area there are 99.70 per cent points of the instantaneous time shift 
curve. So, the propagation% parameter equals 99.70. In this case, the fundal time series mostly runs ahead of the cervical one. 
In panel B, the maximal values of the cross-correlation coefficients are located in the areas of the positive and negative time 
lags. In the area of the positive time lags are located 61.08 per cent points of the instantaneous time shift curve. In this case we 
have disturbed synchronization.
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Fractal analysis serves another example for advanced data
analysis to be utilized in the studies on uterine contractile
activity. Fractals, a relatively new analytical concept of the
last few decades, have been successfully applied in many
areas of science and technology. We performed a compar-
ative study of ten methods of fractal analysis of signals of
intrauterine pressure. We found significant differences
between uterine contractions in healthy volunteers and
women with primary dysmenorrhoea [17]. There was a
correlation between the adjacent elements of the investi-
gated signals. Consequently, the values of fractal dimen-
sion can be objective measures for classifications of
uterine contraction signals and may be used in studies on
preterm labor.
Nonlinear dynamics is one more example of advanced
data analysis that could be implemented for uterine con-
tractility signals. In recent years the physiological signals
obtained from the complex systems like the brain or the
heart have been investigated for possible deterministic
chaotic behavior. The human uterus is undoubtedly a
complex system. Smooth muscles comprising the myo-
metrium interact in a complex manner. We used the tech-
niques of surrogate data analysis to testing for
nonlinearity in the uterine contraction signals. The results
showed that the spontaneous uterine contractions are
considered to contain nonlinear features [16] which indi-
cated that nonlinear dynamics may increase the accessibil-
ity of data for the assessment of biology of uterus, and
consequently, the nature of preterm labor.
Conclusion
After decades of continuous research, especially as no
breakthrough in the interest of pharmaceutical industry
can be seen, only well-planned and coordinated interna-
tional programs may provide additional data of different
aspects of preterm labor. Possible directions for future
research may be related to development of new biophysi-
cal methods of evaluation of uterine activity (allowing
new pharmacologic studies) together with implementa-
tion of novel methodology of analysis of signals and diag-
nosis of molecular genetic malfunctions.
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